Matches in Wikidata for { <http://www.wikidata.org/entity/Q63535253> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q63535253 description "clinical trial" @default.
- Q63535253 description "ensayu clínicu" @default.
- Q63535253 description "klinisch onderzoek" @default.
- Q63535253 description "клінічне випробування" @default.
- Q63535253 description "կլինիկական փորձարկում" @default.
- Q63535253 name "A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)" @default.
- Q63535253 type Item @default.
- Q63535253 label "A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)" @default.
- Q63535253 prefLabel "A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)" @default.
- Q63535253 P1050 Q63535253-D65CA4EE-14D5-405A-83B7-B837CC556D11 @default.
- Q63535253 P1132 Q63535253-8E1C9F50-2804-45C9-B3C8-90EBC9BECC63 @default.
- Q63535253 P1476 Q63535253-9AFA40AF-56A8-4EBF-9050-991520FB78F9 @default.
- Q63535253 P1813 Q63535253-2A5A4A4E-90F4-428B-8A41-89A4CD395D8F @default.
- Q63535253 P2899 Q63535253-9CCD2931-B3F4-4202-888F-BD7325D20109 @default.
- Q63535253 P3098 Q63535253-CCD84E63-C221-4CD4-A99A-C2E9DD98CD73 @default.
- Q63535253 P31 Q63535253-1B991F4C-252B-45E7-9FA9-60FBD412FA25 @default.
- Q63535253 P4135 Q63535253-100BB584-3300-4ADF-8655-DCD4C2ADB52D @default.
- Q63535253 P4844 Q63535253-7FC6ED51-0AB6-4A5B-A2B1-85ED66D7FFD1 @default.
- Q63535253 P4844 Q63535253-A6F29FDE-72EF-4E83-A39C-0BD0B706DFA2 @default.
- Q63535253 P4844 Q63535253-D2894F90-8336-4209-A617-3F463A0CC54B @default.
- Q63535253 P4844 Q63535253-E3EB2792-91BC-468D-BBF2-45FB10CE6638 @default.
- Q63535253 P4844 Q63535253-EAE5EA57-FE91-440A-9E77-E20257B470CE @default.
- Q63535253 P580 Q63535253-2910B755-8FDD-4D49-A1C6-AD969B9611B9 @default.
- Q63535253 P582 Q63535253-971E092A-EC06-4A9E-8201-9575546AC7C3 @default.
- Q63535253 P6099 Q63535253-039A72A2-7F65-409E-AFA2-B62A23ED966A @default.
- Q63535253 P8363 Q63535253-AF938C4D-69E6-43FD-9346-7DB3B0D75B1B @default.
- Q63535253 P859 Q63535253-48B5761E-57DF-40C8-A041-817D1E00BE80 @default.
- Q63535253 P1050 Q114085 @default.
- Q63535253 P1132 "+260" @default.
- Q63535253 P1476 "A Randomized, Double-blind, Parallel-group, Multicenter, Phase III Prospective Non-inferiority Clinical Trial to Assess Efficacy and Safety of Nasacort® Nasal Spray (Triamcinolone, 55µg) in Comparison With Flixonase® Nasal Spray (Fluticasone, 50 µg) in Adults Suffering From PAR (Perennial Allergic Rhinitis) Administered Once a Day for 28 Days" @default.
- Q63535253 P1813 "NASANIF" @default.
- Q63535253 P2899 "+18" @default.
- Q63535253 P3098 "NCT03317015" @default.
- Q63535253 P31 Q30612 @default.
- Q63535253 P4135 "+50" @default.
- Q63535253 P4844 Q1002165 @default.
- Q63535253 P4844 Q1074056 @default.
- Q63535253 P4844 Q1593246 @default.
- Q63535253 P4844 Q2211240 @default.
- Q63535253 P4844 Q27108462 @default.
- Q63535253 P580 "2016-11-30T00:00:00Z" @default.
- Q63535253 P582 "2017-07-10T00:00:00Z" @default.
- Q63535253 P6099 Q42824827 @default.
- Q63535253 P8363 Q78089383 @default.
- Q63535253 P859 Q158205 @default.